Skip to content

Glenohumeral OsteoArthritis Therapy Trial

A Prospective Randomized Trial Comparing Physical Therapy or Home Exercise With No Treatment for Patients With Glenohumeral Osteoarthritis

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07744542
Acronym
GOAT
Enrollment
125
Registered
2026-08-04
Start date
2026-06-17
Completion date
2028-06-30
Last updated
2026-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glenohumeral Arthritis, Shoulder Arthritis Osteoarthritis

Keywords

Shoulder arthritis, Physical therapy, Home Therapy

Brief summary

Arthritis of the shoulder glenohumeral joint is a growing problem in an aging population. Treatment options for glenohumeral arthritis can be grouped into three main categories: 1) shoulder replacement surgery, 2) injections (corticosteroid, hyaluronic acid and PRP) and physical therapy (PT). Surgery comes with risks and the potential for implant failure or revision over time. Therefore, it is typical for doctors to prescribe injections and/or PT before discussing surgery. Sometimes, insurance companies will require PT before considering a shoulder operation. It is unknown if PT is effective for improving function or pain with patients with glenohumeral arthritis. The aim of this study is to compare pain and functional outcomes after undergoing a 12 week PT program, at home PT exercises or delaying conservative treatment.

Interventions

BEHAVIORALPhysical therapy

12 weeks of designated physical therapy focused on improving shoulder strength and range of motion

12 weeks of home therapy program focused on improving shoulder strength and range of motion

Sponsors

State University of New York at Buffalo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized Controlled Trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient diagnosed with glenohumeral arthritis * Patient \> 18 years of age (adults) * Patient provided written informed consent for study participation with IRB approved consent form * Patient is willing and able to comply with scheduled clinical and radiographic evaluations and physical therapy regimen

Exclusion criteria

* -Have had corticosteroid injections in the affected shoulder(s) within 6 weeks of starting physical therapy. * Those that have glenohumeral arthritis that is inflammatory, post traumatic or related to rotator cuff tear arthropathy in nature * Have avascular necrosis of the glenohumeral joint * Have failed a course of 6 weeks of physical therapy within the last year * Have had surgery on the symptomatic shoulder in the past year * Daily use of opioid (excluding tramadol or codeine). * Have dementia * Currently in a physical therapy program for more than 2 weeks * Have planned total shoulder arthroplasty in the next 6 months. * Live in a nursing home * Additionally special populations listed below such as pregnant women, and prisoners will be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Visual analog scale (VAS)Time 0, 6 weeks, 12 weeks, 1 yearmeasures pain from 0 being none and 10 as the worst pain ever felt.
American Shoulder and Elbow Surgeons (ASES)Time 0, 6 weeks, 12 weeks, 1 yearThis score is a 100-point shoulder evaluation tool divided evenly into a pain subscore (50 points) and an activities of daily living (ADL) function subscore (50 points). Higher scores indicate less pain and better shoulder function.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 5, 2026